Interestingly, we found that ITGB6 expression was associated with significantly reduced cancer‐related survival in tumours with high MMP‐11 and MMP‐12 expression but not in those with low expression (Figure 5C, patient characteristics: Table S1). This evidence concerns the gene ITGB6 and neoplasm.